Designed to increase the efficiency and quality of vaccine discovery, the end-to-end enterprise platform supports the full development process for novel vaccines and enables faster testing, simplified production, and reduced costs.
Reduce timelines across cell line development, upstream and downstream process development, formulation, and analytical development.Choose Your Application
QbD. Clone selection. Media optimization. CQA monitoring. Optimizing DSP unit operations. Formulation screening. Genedata Bioprocess® acts as an integrated, end-to-end workflow backbone that provides purpose-built functionalities for all applications across bioprocess development.